The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with ...

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations ...

Merck & Co.’s said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet ...

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

The treatment, tulisokibart, spurred remission of symptoms in more than a quarter ... 27 (UPI) -- Influenced largely by ...

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

Schizophrenia causes persistent delusions and hallucinations and significantly impairs the way patients perceive reality.

A Chinese research team has isolated an antibody from alpacas that can effectively inhibit HIV, providing a promising avenue ...